This site is for healthcare professionals. If you are a member of the public or a patient then please visit our Colonoscopy site.

Reminder Service

How does bowel preparation support the achievement of quality standards in colonoscopy?

High-quality bowel preparation is critical for successful colonoscopy, and is associated with other important performance measures including adenoma detection rate and caecal intubation rate.1 This symposium, led by Prof Dr Michał F. Kamiński and Prof Raf Bisschops, discussed the impact that bowel preparation can have in achieving high-quality standards in colonoscopy.

Watch the 45-minute symposium below to see discussions around the most recent advances in the evolving field of low-volume bowel preparation, and how PLENVU® can support you in optimising outcomes for colonoscopy.

Expertise in Colonoscopy

Norgine's satellite symposium from the ESGE Days 2018 congress

Prof Raf Bisschops

Prof Raf Bisschops

MD PhD, Head of Endoscopy, University Hospitals Leuven, Belgium

Prof Bisschops' main area of research lies currently in advanced endoscopic imaging and therapeutics with a key interest in premalignant conditions such as Barrett's oesophagus, hereditary nonpolyposis colorectal cancer (HNPCC), ulcerative colitis and colorectal polyps.

Prof Dr Michal F. Kamiński

Prof Dr Michał F. Kamiński

MD PhD, The Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland

Prof Dr Kamiński dedicates most of his time to the quality of endoscopy and research on colorectal cancer screening, holding a number of positions as part of his research activities. He is also part of the international editorial boards for Gastrointestinal Endoscopy and Endoscopy journals.


Duration Session Speaker(s)
15 minutes Key performance measures in quality standards in colonoscopy Prof Dr Kamiński
15 minutes PLENVU® in relation to improving outcomes for colonoscopy - what can we learn? Prof Bisschops
15 minutes Questions and discussion Prof Dr Kamiński and Prof Bisschops

Organised and sponsored by Norgine.

This symposium was independent from the ESGE Days 2018 scientific programme.

Adverse events should be reported to your regulatory agency. Adverse events should also be reported to either your local distributor, Norgine Limited, Norgine House, Moorhall Road, Harefield, Uxbridge, Middlesex, UB9 6NS, United Kingdom or using our reporting form.